
The US CDC says Candida auris was detected in 27 US states this year, with 3,437 confirmed cases by 25 July, according to LiveMint. But the Economic Times reports 3,130 cases across…
The US CDC says Candida auris was detected in 27 US states this year, with 3,437 confirmed cases by 25 July, according to LiveMint. But the Economic Times reports 3,130 cases across 23 states as of 18 July, showing disagreement between outlets. The number is about 1,000 lower than the same period last year. California, Texas and Tennessee reported the highest counts. The fungus spreads mostly among seriously ill patients in healthcare facilities, causing skin or bloodstream infections. People with weakened immunity face greater risk.

Testing found widespread resistance to fluconazole, while echinocandins remain effective. The CDC estimates mortality at 30% to 60%, but says the fungus's direct role is difficult to separate from other illnesses. Annual cases continue to rise, but the increase has slowed since 2022.
Headlines painting an alarming picture of a deadly fungus sweeping America risk stoking unnecessary panic. The data show fewer cases than last year, and most patients are already severely ill. Drug resistance is a real concern, but claims that Candida auris is uniformly fatal ignore that many infected people die from underlying conditions. Instead of fear, we need steady vigilance: are India's hospitals ramping up testing and infection control for this pathogen, which has already been reported here?
Sources (3): livemint.com, economictimes.indiatimes.com, timesnownews.com
This story was synthesised by AI from the 3 sources linked above.
Updated: this story now draws on 3 sources.